Multiple clinical trialsincluding SUSTAIN-6 (semaglutide) and REWIND (dulaglutide)showed significant reductions in major adverse cardiovascular events (MACE) such as: Heart attack Stroke Cardiovascular death This benefit appears to be independent of weight loss , suggesting direct protective effects on the arteries, blood pressure, and cholesterol metabolism
In a significant review paper published back in 2002 in the New England Journal of Medicine the increasing prevalence of both Coeliac and Gluten sensitivity was discussed.[1] Accounts of coeliac disease date back to the first century A.D.[2] It was not until the 1940s, however, that the link to gluten ingestion was established
14 The reason GLP-1 drugs are so effective at leveraging the brain to fight inflammation is that, while they mimic the effects of the natural GLP-1 hormone, they are synthetic drugs
According to Garshick, GLP-1 related telogen effluvium is typically caused by stress as your body attempts to conserve energy and focus on supporting your vital organs, of which hair is not one
Key areas * Cancer * Diabetes * Cardiovascular disease * Autoimmune disorders To view or add a comment, sign in Were excited to present new clinical and translational data for icovamenib, our investigational oral menin inhibitor, at #ADA2026
Oral semaglutide options begin at $289/mo (or $249/mo on the 6-month plan), and for patients seeking dual-compound protocols, GLP-Squared Injection (combining semaglutide and tirzepatide) is $289/mo month-to-month (or $249/mo on the 3-month plan)